FOXI1, forkhead box I1, 2299

N. diseases: 42; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Sensorineural Hearing Loss (disorder)
0.100 Biomarker disease HPO
CUI: C0020502
Disease: Hyperparathyroidism
Hyperparathyroidism
0.100 Biomarker disease HPO
CUI: C0020676
Disease: Hypothyroidism
Hypothyroidism
0.100 Biomarker disease HPO
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.100 Biomarker group HPO
CUI: C0035229
Disease: Respiratory Insufficiency
Respiratory Insufficiency
0.100 Biomarker phenotype HPO
CUI: C0037822
Disease: Speech Disorders
Speech Disorders
0.100 Biomarker group HPO
CUI: C0040583
Disease: Tracheal Stenosis
Tracheal Stenosis
0.100 Biomarker disease HPO
CUI: C0042571
Disease: Vertigo
Vertigo
0.100 Biomarker phenotype HPO
CUI: C0342162
Disease: Compensated hypothyroidism
Compensated hypothyroidism
0.100 Biomarker disease HPO
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.100 Biomarker disease HPO
CUI: C1843865
Disease: Vestibular dysfunction
Vestibular dysfunction
0.100 Biomarker phenotype HPO
CUI: C1862050
Disease: Cochlear malformation
Cochlear malformation
0.100 Biomarker phenotype HPO
Congenital sensorineural hearing loss
0.100 Biomarker disease HPO
CUI: C2676974
Disease: Hypoplasia of the cochlea
Hypoplasia of the cochlea
0.100 Biomarker phenotype HPO
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.100 Biomarker group HPO
Abnormality of metabolism/homeostasis
0.100 Biomarker phenotype HPO
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.020 GeneticVariation disease BEFREE Finally, we identified a novel, rare cell type that we call the 'pulmonary ionocyte', which co-expresses FOXI1, multiple subunits of the vacuolar-type H<sup>+</sup>-ATPase (V-ATPase) and CFTR, the gene that is mutated in cystic fibrosis. 30069046 2018
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.020 AlteredExpression disease BEFREE Knockout of Foxi1 in mouse ionocytes causes loss of Cftr expression and disrupts airway fluid and mucus physiology, phenotypes that are characteristic of cystic fibrosis. 30069044 2018
CUI: C0002881
Disease: Anemia, Hemolytic, Congenital
Anemia, Hemolytic, Congenital
0.010 Biomarker disease BEFREE Additional manifestations include bone demineralization (rickets, osteomalacia), growth deficiency, sensorineural hearing loss (in <i>ATP6V0A4-</i>, <i>ATP6V1B1-</i>, and <i>FOXI1-</i>dRTA), and hereditary hemolytic anemia (in some individuals with <i>SLC4A1-</i>dRTA). 31600869 2019
CUI: C0346255
Disease: Oncocytoma, renal
Oncocytoma, renal
0.010 Biomarker disease BEFREE Although the origin of RO remains unclear, our findings suggest that FOXI1 immunohistochemistry is useful in differential diagnosis of RO from chRCC with overlapping histology. 31177114 2019
CUI: C1266042
Disease: Chromophobe Renal Cell Carcinoma
Chromophobe Renal Cell Carcinoma
0.010 Biomarker disease BEFREE Although the origin of RO remains unclear, our findings suggest that FOXI1 immunohistochemistry is useful in differential diagnosis of RO from chRCC with overlapping histology. 31177114 2019
CUI: C1704380
Disease: Distal Renal Tubular Acidosis
Distal Renal Tubular Acidosis
0.010 GeneticVariation disease BEFREE Mutations in adenosine triphosphate ATP6V1 (B1 H<sup>+</sup>-ATPase subunit), ATPV0A4 (a4 H<sup>+</sup>-ATPase subunit), SLC4A1 (anion exchanger 1), and FOXI1 (forkhead transcription factor) cause distal renal tubular acidosis type I. Carbonic anhydrase II mutations affect several nephron segments and give rise to a mixed proximal and distal phenotype. 31300090 2019
CUI: C0392485
Disease: Congenital diverticulum of pharynx
Congenital diverticulum of pharynx
0.010 Biomarker disease BEFREE Foxi1 promotes late-stage pharyngeal pouch morphogenesis through ectodermal Wnt4a activation. 29932895 2018
CUI: C0007134
Disease: Renal Cell Carcinoma
Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE Chromophobe RCCs express FOXI1-driven genes that define collecting duct intercalated cells, whereas HNF-regulated genes, specific for proximal tubule cells, are an integral part of clear cell and papillary RCC transcriptomes. 28793269 2017
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.010 AlteredExpression disease BEFREE In conclusion, to the best of our knowledge, our findings are the first to demonstrate that Foxi1 is a key player in the transcriptional control of miR-491-5p and that miR-491-5p acts as an anti-oncogene by targeting Wnt3a/β-catenin signaling in GC. 28358374 2017